Amidst Chinese Aggression U.S. Cannot Afford To Dilute Its Ip Laws Opinion
Progress is being made against COVID-19 thanks to an unprecedented response by the biopharmaceutical sector. Hundreds of potential treatments and vaccines are currently being tested and more than one-half of this research and development is occurring in the U.S. But China is making gains in its intellectual property protections that will have far more important long-term implications in its race to develop and grow its own innovation economy. China has turbocharged its efforts to safeguard its own IP with its recent announcement of its “Iron Fist” IP enforcement plan....